Maravai LifeSciences
MRVI
MRVI
217 hedge funds and large institutions have $1.2B invested in Maravai LifeSciences in 2024 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 67 increasing their positions, 67 reducing their positions, and 35 closing their positions.
Holders
217
Holders Change
+11
Holders Change %
+5.34%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
46
Increased
67
Reduced
67
Closed
35
Calls
$2.18M
Puts
$236K
Net Calls
+$1.94M
Net Calls Change
+$632K
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$33.7M |
2 |
PD
2
Point72 (DIFC)
Dubai,
United Arab Emirates
|
$22.1M |
3 |
3
Goldman Sachs
New York
|
$16.9M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$98.7M |
5 |
5
Morgan Stanley
New York
|
$22.4M |